Multiomics analysis of adaptation to repeated DNA damage in prostate cancer cells

References

• McDermott N, Meunier A, Mooney B, et al. Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep. 2016;6(1):34796. DOI:10.1038/srep34796
   PubMedGoogle Scholar
• Skvortsova I, Skvortsov S, Stasyk T, et al. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics. 2008;8(21):4521–18. DOI:10.1002/pmic.200800113
   PubMed Web of Science ®Google Scholar
• Sutton LP, Jeffreys SA, Phillips JL, et al. DNA methylation changes following DNA damage in prostate cancer cells. Epigenetics. 2019;14(10):1–14. DOI:10.1080/15592294.2019.1629231
   PubMed Web of Science ®Google Scholar
• Young A, Berry R, Holloway AF, et al. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization. BMC Cancer. 2014;14(1):808. DOI:10.1186/1471-2407-14-808
   PubMedGoogle Scholar
• Giunta S, Belotserkovskaya R, Jackson SP. DNA damage signaling in response to double-strand breaks during mitosis. J Cell Bio. 2010;190(2):197–207.
   PubMed Web of Science ®Google Scholar
• Du P, Zhang X, Huang C-C, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinf. 2010;11(1):587. DOI:10.1186/1471-2105-11-587
   PubMedGoogle Scholar
• Wilkinson EJ, Woodworth AM, Parker M, et al. Epigenetic regulation of the ITGB4 gene in prostate cancer. Exp Cell Res. 2020;392(2):112055. DOI:10.1016/j.yexcr.2020.112055
   PubMed Web of Science ®Google Scholar
• de Llobet LI, Baro, M, Figueras, A, et al. Development and characterization of an isogenic cell line with a radioresistant phenotype. Clin Transl Oncol. 2013;15(3):189–197. DOI:10.1007/s12094-012-0898-8
   PubMed Web of Science ®Google Scholar
• Bhasin JM, Lee B, Matkin L, et al. Methylome-wide sequencing detects DNA hypermethylation distinguishing indolent from aggressive prostate cancer. Cell Rep. 2015;13(10):2135–2146. DOI:10.1016/j.celrep.2015.10.078
   PubMed Web of Science ®Google Scholar
• Russo G, Landi R, Pezone A, et al. DNA damage and repair modify DNA methylation and chromatin domain of the targeted locus: mechanism of allele methylation polymorphism. Sci Rep. 2016;6(1):33222. DOI:10.1038/srep33222
   PubMedGoogle Scholar
• Mortusewicz O, Schermelleh L, Walter J, et al. Recruitment of DNA methyltransferase I to DNA repair sites. Proc Nat Acad Sci. 2005;102(25):8905–8909. DOI:10.1073/pnas.0501034102
   PubMed Web of Science ®Google Scholar
• Cowell IG, Sunter NJ, Singh PB, et al. γH2AX foci form preferentially in euchromatin after ionising-radiation. PLoS ONE. 2007;2(10):e1057. DOI:10.1371/journal.pone.0001057
   PubMed Web of Science ®Google Scholar
• Vasireddy RS, Karagiannis TC, El-Osta A. γ-radiation-induced γH2AX formation occurs preferentially in actively transcribing euchromatic loci. Cell Mol Life Sci. 2010;67(2):291–294.
   PubMed Web of Science ®Google Scholar
• Moran S, Arribas C, Esteller M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 2016;8(3):389–399.
   PubMed Web of Science ®Google Scholar
• Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 2014;26(4):577–590.
   Google Scholar
• Chen X, Liu L, Mims J, Punska EC, Williams KE, Zhao W, Arcaro KF, Tsang AW, Zhou X, Furdui CM. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors. Epigenetics. 2015;10(6):545–561.
   PubMed Web of Science ®Google Scholar
• Kim E, Park AK, Dong SM et al. Global analysis of CpG methylation reveals epigenetic control of the radiosensitivity in lung cancer cell lines. Oncogene. 2010;29(33):4725. DOI:10.1038/onc.2010.223
   Google Scholar
• Antwih DA, Gabbara KM, Lancaster WD, et al. Radiation-induced epigenetic DNA methylation modification of radiation-response pathways. Epigenetics. 2013;8(8):839–848. DOI:10.4161/epi.25498
   PubMed Web of Science ®Google Scholar
• Sen T, Sen N, Noordhuis MG, et al. OGDHL is a modifier of AKT-dependent signaling and NF-κB function. PloS one. 2012;7(11):e48770. DOI:10.1371/journal.pone.0048770.
   Google Scholar
• Fedorova M, Kudryavtseva AV, Lakunina VA, et al. Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer. Mol Biol. 2015;49(4):608–617. DOI:10.1134/S0026893315040044
   Web of Science ®Google Scholar
• Reich S, Nguyen CDL, Has C, et al. A multi-omics analysis reveals the unfolded protein response regulon and stress-induced resistance to folate-based antimetabolites. Nat Commun. 2020;11(1):2936. DOI:10.1038/s41467-020-16747-y
   PubMed Web of Science ®Google Scholar
• Madden E, Logue SE, Healy SJ, et al. The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol Cell. 2019;111(1):1–17. DOI:10.1111/boc.201800050
   PubMed Web of Science ®Google Scholar
• Corazzari M, Gagliardi M, Fimia GM, et al. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol. 2017;7:78.
   PubMed Web of Science ®Google Scholar
• Pootrakul L, Datar RH, Shi S-R, et al. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clin Cancer Res. 2006;12(20):5987–5993. DOI:10.1158/1078-0432.CCR-06-0133
   PubMed Web of Science ®Google Scholar
• Fels DR, Koumenis C. The PERK/eIf2α/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther. 2006;5(7):723–728.
   PubMed Web of Science ®Google Scholar
• Shuda M, Kondoh N, Imazeki N, et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol. 2003;38(5):605–614. DOI:10.1016/S0168-8278(03)00029-1
   PubMed Web of Science ®Google Scholar
• So AYL, de la Fuente E, Walter P, et al. The unfolded protein response during prostate cancer development. Cancer Metast Rev. 2009;28(1–2):219–223. DOI:10.1007/s10555-008-9180-5
   PubMed Web of Science ®Google Scholar
• Garg AD, Maes H, van Vliet AR, et al. Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress. Mol Cell Oncol. 2015;2(1):e975089. DOI:10.4161/23723556.2014.975089
   PubMedGoogle Scholar
• Gjymishka A, Su N, Kilberg MS. Transcriptional induction of the human asparagine synthetase gene during the unfolded protein response does not require the ATF6 and IRE1/XBP1 arms of the pathway. Biochem J. 2009;417(3):695–703.
   PubMedGoogle Scholar
• Ying W, Chen Y, Alano CC, et al. Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes. J Cereb Blood Flow Metab. 2002;22(7):774–779. DOI:10.1097/00004647-200207000-00002
   PubMed Web of Science ®Google Scholar
• Murata MM, Kong X, Moncada E, et al. NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Mol Biol Cell. 2019;30(20):2584–2597. DOI:10.1091/mbc.E18-10-0650
   PubMed Web of Science ®Google Scholar
• Brace LE, Vose SC, Stanya K, et al. Increased oxidative phosphorylation in response to acute and chronic DNA damage. NP J Aging Mech Dis. 2016;2(1):16022. DOI:10.1038/npjamd.2016.22
   PubMedGoogle Scholar
• Franke WW, Grund C, Kuhn C, et al. Formation of cytoskeletal elements during mouse embryogenesis: iII. Primary mesenchymal cells and the first appearance of vimentin filaments. Differentiation. 1982;23(1–3):43–59. DOI:10.1111/j.1432-0436.1982.tb01266.x
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yan Q, Long X, et al. Vimentin affects the mobility and invasiveness of prostate cancer cells. Cell Biochem And Funct: Cell Biochem And Its Modulation By Active Agents Or Dis. 2008;26(5):571–577. DOI:10.1002/cbf.1478
   Google Scholar
• Lang SH, Hyde C, Reid IN, et al. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate. 2002;52(4):253–263. DOI:10.1002/pros.10088
   PubMed Web of Science ®Google Scholar
• Lee E, Kim J-Y, Kim T-K, et al. Methyltransferase-like protein 7A (METTL7A) promotes cell survival and osteogenic differentiation under metabolic stress. Cell Death Discovery. 2021;7(1):154. DOI:10.1038/s41420-021-00555-4
   PubMed Web of Science ®Google Scholar
• Jun F, Peng Z, Zhang Y, Shi D. Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma. Gynecol Oncol. 2020;157(1):268–279.
   Google Scholar
• Song H, Liu D, Wang L, et al. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma. Mol Cancer. 2022;21(1):43. DOI:10.1186/s12943-022-01519-7
   PubMed Web of Science ®Google Scholar
• Huber W, Carey VJ, Gentleman R, et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods. 2015;12(2):115. DOI:10.1038/nmeth.3252
   PubMed Web of Science ®Google Scholar
• Chen Y-A, Lemire M, Choufani S, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8(2):203–209. DOI:10.4161/epi.23470
   PubMed Web of Science ®Google Scholar
• Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363–1369. DOI:10.1093/bioinformatics/btu049
   PubMed Web of Science ®Google Scholar
• Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analyzing data from Illumina’s HumanMethylation450 platform. Bioinformatics. 2016;32(2):286–288.
   PubMed Web of Science ®Google Scholar
• Maksimovic J, Gordon L, Oshlack A. SWAN: subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 2012;13(6):R44.
   PubMed Web of Science ®Google Scholar